Legislators
Bills
Statements
Lobbying
Travel
- Bills
- H.R.1035
H.R.1035: Prescription Drug Price Transparency Act
About This Bill
- This bill was introduced in the 116th Congress
- This bill is primarily about health
- Introduced Feb. 7, 2019
- Latest Major Action Feb. 7, 2019
- See the one similar bills introduced in other congresses.
Bill Sponsor
Bill Cosponsors
38 (13 Democrats, 25 Republicans)
Bill Version
- Introduced in House - Feb. 7, 2019
Bill Summary
Prescription Drug Price Transparency Act This bill establishes additional requirements for prescription drug plan sponsors (PDPs) under Medicare and Medicare Advantage, as well as health insurance carriers under the Federal Employees Health Benefits Program, relating to the methodology of payments to pharmacies and the use of pharmacy benefits managers (PBMs). Specifically, such PDPs and carriers must disclose specified information to...
(Source: Library of Congress)
What Lawmakers Are Saying About This Bill
Bill Actions
Date | Description |
---|---|
Feb. 7, 2019 |
Referred to the Subcommittee on Health.
|
Feb. 7, 2019 |
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Oversight and Reform, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
|
Feb. 7, 2019 |
Introduced in the House by Doug Collins (R-Ga.) |